The study, published in the Journal of Bone and Joint Surgery, included 321 patients, according to a June 25 news release from the devicemaker.
Researchers found that 73.5% of patients who had surgery with the TOPS arthroplasty system reached composite clinical success at 24 months postoperatively compared to 25.5% in the fusion group. The arthroplasty group also outperformed the fusion group in most patient-reported outcome measures, and the fusion group had higher rates of symptomatic adjacent segment degeneration and revisions.
Read the study here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
